In the BioHarmony Drug Report Database

"Preview" Icon

Pegcetacoplan

Empaveli (pegcetacoplan) is a protein pharmaceutical. Pegcetacoplan was first approved as Empaveli on 2021-05-14. Empaveli’s patents are valid until 2038-04-09 (FDA).

 

Trade Name

 

Empaveli
 

Common Name

 

pegcetacoplan
 

ChEMBL ID

 

CHEMBL4298211
 

Indication

 

 

Drug Class

 

Pegylated compounds

Image (chem structure or protein)

Pegcetacoplan structure rendering